MaxCyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MaxCyte and other ETFs, options, and stocks.

About MXCT

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. 

CEO
Maher Masoud
CEOMaher Masoud
Employees
114
Employees114
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
1998
Founded1998
Employees
114
Employees114

MXCT Key Statistics

Market cap
215.83M
Market cap215.83M
Price-Earnings ratio
-5.42
Price-Earnings ratio-5.42
Dividend yield
—
Dividend yield—
Average volume
479.44K
Average volume479.44K
High today
$2.19
High today$2.19
Low today
$2.02
Low today$2.02
Open price
$2.19
Open price$2.19
Volume
387.69K
Volume387.69K
52 Week high
$5.20
52 Week high$5.20
52 Week low
$2.00
52 Week low$2.00

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MXCT. This list is generated using Robinhood data, and it’s not a recommendation.
ChargePoint
Plug Power
SoFi Technologies
Bionano Genomics
IonQ
Ginkgo Bioworks
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.